Position in INCY
as of Mar 31, 2026
· filed Apr 10, 2026
Position Value
$4,235
New position
Shares Held
45
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Daytona Street Capital LLC holds $1,529,388 across 7 Biotechnology names. INCY ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DRTS |
Alpha Tau Medical Ltd.
|
146,106 | $1,032,969 | |
| 2 | ELDN |
Eledon Pharmaceuticals, Inc.
|
81,166 | $249,991 | |
| 3 | OBIO |
Orchestra BioMed Holdings, Inc.
|
52,600 | $223,550 | |
| 4 | MAIA |
MAIA Biotechnology, Inc.
|
7,500 | $10,500 | |
| 5 | EVGN |
Evogene Ltd.
|
9,586 | $7,381 | |
| 6 | INCY |
Incyte Corp
This page
|
45 | $4,235 | |
| 7 | MRNA |
Moderna, Inc.
|
15 | $762 |
All Filings in INCY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,235 | 45 | Shares | Sole | 2026-04-10 | |
| No filing history on record for this holder in this stock. | ||||||